Genitrix began trading in early 1998
and has grown every year since then to become one of the UK's most
respected veterinary products companies. We aim to work in close
partnership with the veterinary sector to promote ever higher
standards of animal health and welfare.
Genitrix is run by a small, dedicated and long-serving team, most
of whom have strong veterinary or pharmaceutical experience. Our
portfolio of products is constantly increasing as we seek out and
develop novel solutions to well recognised veterinary problems.
Our products include innovative, often ground- breaking therapies
to advance veterinary care for companion animals such as dogs and
cats, as well as for exotic pets including rabbits, guinea pigs,
small rodents, ornamental birds and reptiles. We also offer a range
equine therapies and our involvement in the equine sector is growing
Genitrix is the UK's fastest growing veterinary pharmaceutical company. It offers a wide range of veterinary therapies, including:
Xeno-450 and Xeno 50-Mini - the first ivermectin 'spot-on' treatments for parasite control in small pets such as rabbits, guinea pigs, ferrets and small rodents.
Xeno 200 Spray - an ivermectin based parasite control spray for topical use in rabbits, guinea pigs, ferrets, rodents, birds and reptiles
Lapizole - a palatable fenbendazole product to prevent and treat E. cuniculi infection in rabbits
Mycozole - the first miconazole nitrate treatment to treat fungal skin infections in many pet species to be supplied in an easy-to use spray format
RIP Fleas - the fastest growing environmental flea treatment on the market
HY-50 - high dose sodium hyaluraonate in a low volume for the treatment of equine non-infectious joint inflammation in horses
KBr Tablets - potassium bromide tablets for the control of refractory epilepsy in dogs
irap - a revolutionary equine joint treatment which uses a horse's own blood to produce anti-inflammatory proteins